Recce Pharmaceuticals Ltd (rce) Logo

Recce Pharmaceuticals Ltd (RCE)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

RCE ASX Chart

Snapshot

Recce Pharmaceuticals Ltd (RCE) is a drug discovery business engaged in development of new class of Synthetic Anti-Infectives designed to address the global health problems of antibiotic-resistant superbugs and emerging viral pathogens. Recce's anti-infective pipeline includes three patented, broad-spectrum, synthetic polymer anti-infectives: RECCE 327, RECCE 435 and RECCE 529.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2023 YTD
1 Year
vs Sector (1yr) -22.66%
vs ASX 200 (1yr) -29.41%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 939 of 2,408
Sector Rank 67 of 220

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies BD1 / VLS / QTM
EPS -$0.074
DPS $0.00
Book Value Per Share -$0.013

Broker Consensus

RCE is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Sydney NSW 2000
Website www.recce.com.au
Registry Automic Group
Auditor BDO Audit (WA) Pty Ltd
Date Listed 15 Jan 2016

Upcoming Calendar (Forecasted)

Date Event
26/02/2024 Report (Interim)
29/08/2024 Report (Prelim)
27/09/2024 Report (Annual)

Former Company Names

  • Recce Limited (RCE), 16/01/2018

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

RCE directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
29/09/23 Alistair McKeough Issued 961 $0.439 $422 Rights issue
29/09/23 Justin Ward Issued 6,114 $0.440 $2,690 Rights issue
29/09/23 James Graham Transfer 262,347 $0.485 $127,238 As advised by the company
29/09/23 James Graham Transfer 262,347 $0.485 $127,238 As advised by the company
29/09/23 James Graham Issued 233,430 $0.440 $102,709 Rights issue
22/06/23 James Graham Buy +500,000 $0.590 $295,000 On-market trade
15/06/23 James Graham Transfer 2,577,985 $0.510 $1,314,772 As advised by the company
15/06/23 James Graham Transfer 2,577,985 $0.510 $1,314,772 As advised by the company
15/11/22 Alistair McKeough Issued 1,125,000 $0.278 $312,412 Issue of options
21/06/21 Michele Dilizia Sell +175,000 $1.02 ($178,238) On-market trade
16/06/21 James Graham Buy +47,850 $1.04 $50,003 On-market trade
22/02/21 James Graham Issued 2,250,000 $1.03 $2,317,500 Issue of options
22/02/21 Alan Dunton Issued 1,125,000 $1.03 $1,158,750 Issue of options
22/02/21 John Prendergast Issued 2,175,000 $1.03 $2,240,250 Issue of options
22/02/21 Justin Ward Issued 600,000 $1.03 $618,000 Issue of options
22/02/21 Michele Dilizia Issued 1,500,000 $1.03 $1,545,000 Issue of options
04/12/20 Alan Dunton Issued 60,000 $1.22 $73,200 Director remuneration
28/08/20 Michele Dilizia Buy +577,212 $1.36 $785,008 Conversion of securities
28/08/20 Michele Dilizia Exercise 577,212 $1.36 $785,008 Conversion of securities
28/08/20 James Graham Buy +356,250 $1.36 $484,500 Conversion of securities
28/08/20 James Graham Buy +389,712 $1.36 $530,008 Conversion of securities
28/08/20 James Graham Exercise 745,962 $1.36 $1,014,508 Conversion of securities
09/07/20 James Graham Buy +356,250 $1.05 $374,062 Conversion of securities
09/07/20 James Graham Buy +389,712 $1.05 $409,197 Conversion of securities
09/07/20 James Graham Exercise 745,962 $1.05 $783,260 Conversion of securities
09/07/20 Michele Dilizia Buy +577,212 $1.05 $606,072 Conversion of securities
09/07/20 Michele Dilizia Exercise 577,212 $1.05 $606,072 Conversion of securities
19/12/19 Justin Ward Issued 43,478 $0.310 $13,478 Director remuneration
19/12/19 James Graham Issued 192,307 $0.260 $50,000 Placement
08/08/19 Michele Dilizia Sell +45,000 $0.222 ($9,975) On-market trade
07/08/19 Michele Dilizia Sell +277,000 $0.217 ($60,180) On-market trade
06/03/19 James Graham Buy +650,000 $0.155 $100,460 On-market trade
15/02/19 John Prendergast Issued 250,000 $0.155 $38,750 Director remuneration
09/03/17 James Graham Sell +79,960 $0.250 ($19,956) On-market trade
16/01/17 Graham Melrose Buy +1,059,000 $0.295 $312,405 Conversion of securities
16/01/17 Graham Melrose Exercise 1,059,000 $0.295 $312,405 Conversion of securities
12/09/16 Bernadette Murdoch Buy +20,000 $0.250 $5,000 On-market trade
15/07/16 Graham Melrose Exercise 3,543,000 $0.265 $938,895 Conversion of securities
15/07/16 Graham Melrose Buy +3,543,000 $0.265 $938,895 Conversion of securities
16/02/16 James Graham Exercise 745,962 $0.335 $249,897 Conversion of securities
16/02/16 James Graham Buy +389,712 $0.335 $130,554 Conversion of securities
16/02/16 Ian Brown Exercise 56,250 $0.335 $18,844 Conversion of securities
16/02/16 Ian Brown Buy +56,250 $0.335 $18,844 Conversion of securities
16/02/16 Michele Dilizia Buy +577,212 $0.335 $193,366 Conversion of securities
16/02/16 Graham Melrose Exercise 1,473,000 $0.335 $493,455 Conversion of securities
16/02/16 Graham Melrose Buy +1,473,000 $0.335 $493,455 Conversion of securities
16/02/16 Dongke Zhang Exercise 56,250 $0.335 $18,844 Conversion of securities
16/02/16 James Graham Buy +356,250 $0.335 $119,344 Conversion of securities
16/02/16 Michele Dilizia Exercise 577,212 $0.335 $193,366 Conversion of securities
16/02/16 Dongke Zhang Buy +56,250 $0.335 $18,844 Conversion of securities
Show All

Director Interests

The current holdings of RCE directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Justin Ward 29/09/2023 165,080 N/A 600,000 N/A
Alistair McKeough 29/09/2023 N/A 25,961 1,125,000 N/A
James Graham 29/09/2023 0 6,503,015 2,250,000 N/A
John Prendergast 30/06/2023 250,000 N/A 2,175,000 N/A
Michele Dilizia 30/06/2023 3,543,485 N/A 1,500,000 N/A
Alan Dunton 30/06/2023 N/A 70,000 1,125,000 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Sep 18, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Graham Melrose And Olga Melrose 37,028,311 18.81%
Hsbc Custody Nominees (Australia) Limited 13,162,919 6.69%
M Rogers and A Veliss 7,000,000 3.56%
Mr James Graham 6,531,932 3.32%
Acuity Capital Investment Management Pty Ltd <Acuity Capital Holdings A/c> 4,500,000 2.29%
Citicorp Nominees Pty Limited 3,694,057 1.88%
Ms Michele Keryn Dilizia 3,543,485 1.80%
Acewood Investments Pty Ltd <Chivers Super Fund A/C> 3,184,616 1.62%
Mr John James Liddelow <John Liddelow A/C> 2,910,000 1.48%
Pejay Pty Limited 2,500,000 1.27%
BNP Paribas Nominees Pty Ltd Acf Clearstream 2,487,783 1.26%
Merrill Lynch (Australia) Nominees Pty Limited 2,449,559 1.24%
LDU Pty Ltd 2,143,881 1.09%
Querion Pty Ltd 2,100,000 1.07%
Haultrans Management Pty Limited <Successful Super Fund A/C> 1,800,000 0.91%
Bnp Paribas Noms Pty Ltd <Drp> 1,721,246 0.87%
Mr Michael Noel Aarons & Mrs Mami Aarons <The Aarons Superfund A/C> 1,437,498 0.73%
Mark David Swinn 1,314,720 0.67%
Mr Nikolai Shirobokov & Mrs Svetlana Shirobokov 1,181,974 0.60%
20 BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <DRP A/C> 1,095,061 0.56%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 1,033 1,397 679 1,178 207 4,494

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
FIL Limited 18/09/2023 15,144,466 7.69
Graham John Hamilton Melrose & Olga Mary Melrose 18/09/2023 37,028,311 18.81

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
18-09-23 FIL Limited and the entities 15,144,466 -- 7.69

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.625 30 June
2022 $0.890 30 June
2021 $0.930 30 June
2020 $0.670 30 June
2019 $0.215 28 June
2018 $0.190 29 June
2017 $0.205 28 June
2016 $0.250 28 June
RCE Historical Price Data (CSV)
Up to 20 years of EOD share price history
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.